Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine vs remifentanil infusion for postoperative pain after laparoscopic cholecystectomy
IRCT20141009019470N89Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in acute cholecystitis comparing Intravenous lidocaine infusion with Intravenous remifentanil infusion (2 arms). Primary endpoint: Postoperative pain intensity. Started Nov 2019; status: completed.
02
Drugs
lidocaineremifentanil
03
Conditions
acute cholecystitis
Beyond the preview
Go deeper on IRCT20141009019470N89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N89.